Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Akero Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AKRO is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 265
- +10 vs. Q2 2025
- Shares held
- 91.5M
- −666.0K (−0.7%) vs. Q2 2025
- Total value
- $4.34B
- −$573.4M (−11.7%) vs. Q2 2025
- New holders
- 46
- 75 more added
- Sold out
- 36
- 92 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 5 | $533.0K |
| Q3 2025 | 265 | $4.34B |
| Q2 2025 | 257 | $4.92B |
| Q1 2025 | 240 | $3.50B |
| Q4 2024 | 191 | $2.06B |
| Q3 2024 | 168 | $2.09B |
| Q2 2024 | 153 | $1.68B |
| Q1 2024 | 173 | $1.85B |
| Q4 2023 | 157 | $1.38B |
| Q3 2023 | 181 | $2.90B |
| Q2 2023 | 157 | $2.63B |
| Q1 2023 | 156 | $1.84B |
| Q4 2022 | 162 | $2.66B |
| Q3 2022 | 146 | $1.59B |
| Q2 2022 | 113 | $329.6M |
| Q1 2022 | 103 | $499.2M |
| Q4 2021 | 97 | $746.8M |
| Q3 2021 | 103 | $626.0M |
| Q2 2021 | 97 | $684.2M |
| Q1 2021 | 109 | $913.6M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Akero Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Propel Bio Management, LLC | 228,884 | $10.9M | 10.88% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 230,600 | $10.9M | 1.21% | +33,000+16.7% | Added |
| B Group, Inc. | 232,446 | $11.0M | 10.55% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 236,089 | $11.2M | 0.00% | −1,594−0.7% | Reduced |
| Readystate Asset Management LP | 237,908 | $11.3M | 0.55% | −403,015−62.9% | Reduced |
| Foresite Capital Management VI LLC | 244,900 | $11.6M | 4.49% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 248,079 | $11.8M | 1.00% | −18,088−6.8% | Reduced |
| JPMorgan Chase & Co | 288,970 | $13.7M | 0.00% | −24,523−7.8% | Reduced |
| Ameriprise Financial Inc | 291,593 | $13.8M | 0.00% | +18,148+6.6% | Added |
| Schonfeld Strategic Advisors LLC | 303,814 | $14.4M | 0.10% | +162,508+115.0% | Added |
| Baker Bros. Advisors LP | 324,630 | $15.4M | 0.11% | 00.0% | Unchanged |
| Jain Global LLC | 325,132 | $15.4M | 0.20% | −20,240−5.9% | Reduced |
| University of Wisconsin Foundation | 328,504 | $15.6M | 13.21% | 00.0% | Unchanged |
| UBS Group AG | 335,678 | $15.9M | 0.00% | −1,693,209−83.5% | Reduced |
| Hudson Bay Capital Management LP | 338,500 | $16.1M | 0.10% | −48,023−12.4% | Reduced |
| Morgan Stanley | 339,922 | $16.1M | 0.00% | −353,334−51.0% | Reduced |
| Frazier Life Sciences Management, L.P. | 366,784 | $17.4M | 0.52% | 00.0% | Unchanged |
| Summit Partners Public Asset Management, LLC | 377,152 | $17.9M | 0.58% | +10,155+2.8% | Added |
| Principal Financial Group Inc | 378,858 | $18.0M | 0.01% | −11,316−2.9% | Reduced |
| First Turn Management, LLC | 397,010 | $18.9M | 2.83% | +282,456+246.6% | Added |
| Voya Investment Management LLC | 409,539 | $19.4M | 0.02% | −7,884−1.9% | Reduced |
| Deutsche Bank AG | 418,975 | $19.9M | 0.01% | +76,977+22.5% | Added |
| Vivo Capital, LLC | 434,689 | $20.6M | 1.66% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 435,293 | $20.7M | 0.34% | +235,293+117.6% | Added |
| Sofinnova Investments, Inc. | 473,625 | $22.5M | 1.38% | −75,163−13.7% | Reduced |
| Braidwell LP | 475,400 | $22.6M | 0.67% | +475,400 | New |
| Weiss Asset Management LP | 486,000 | $23.1M | 0.33% | +457,474+1,603.7% | Added |
| Barclays PLC | 487,230 | $23.1M | 0.01% | −46,186−8.7% | Reduced |
| Standard Life Aberdeen plc | 502,913 | $23.9M | 0.04% | +111,313+28.4% | Added |
| OrbiMed Advisors LLC | 526,200 | $25.0M | 0.60% | +314,900+149.0% | Added |
| Loomis Sayles & Co L P | 527,175 | $25.0M | 0.03% | −13,613−2.5% | Reduced |
| Charles Schwab Investment Management Inc | 612,126 | $29.1M | 0.00% | −2,140−0.3% | Reduced |
| Northern Trust Corp | 626,019 | $29.7M | 0.00% | −8,307−1.3% | Reduced |
| Rock Springs Capital Management LP | 626,526 | $29.7M | 1.74% | −14,000−2.2% | Reduced |
| Woodline Partners LP | 639,598 | $30.4M | 0.14% | −1,827,752−74.1% | Reduced |
| Silverarc Capital Management, LLC | 643,636 | $30.6M | 4.42% | −70,175−9.8% | Reduced |
| American Century Companies Inc | 663,442 | $31.5M | 0.02% | +663,442 | New |
| Citadel Advisors LLC | 685,842 | $32.6M | 0.03% | −483,840−41.4% | Reduced |
| Long Focus Capital Management, LLC | 720,000 | $34.2M | 1.95% | 00.0% | Unchanged |
| Redmile Group, LLC | 747,818 | $35.5M | 3.45% | −26,493−3.4% | Reduced |
| Dimensional Fund Advisors LP | 810,568 | $38.5M | 0.01% | +236,880+41.3% | Added |
| Goldman Sachs Group Inc | 855,766 | $40.6M | 0.01% | +90,025+11.8% | Added |
| Pictet Asset Management Holding SA | 926,441 | $44.0M | 0.04% | −60,192−6.1% | Reduced |
| Holocene Advisors, LP | 1,055,186 | $50.1M | 0.12% | −20,456−1.9% | Reduced |
| Polar Capital Holdings Plc | 1,058,776 | $50.3M | 0.24% | +1,058,776 | New |
| FMR LLC | 1,079,657 | $51.3M | 0.00% | +147,731+15.9% | Added |
| Perceptive Advisors LLC | 1,135,766 | $53.9M | 1.56% | +219,879+24.0% | Added |
| Logos Global Management LP | 1,200,000 | $57.0M | 5.63% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,217,044 | $57.8M | 0.06% | −201,171−14.2% | Reduced |
| Bank of America Corp | 1,297,438 | $61.6M | 0.00% | −23,023−1.7% | Reduced |
| Point72 Asset Management, L.P. | 1,663,339 | $79.0M | 0.17% | −1,047,590−38.6% | Reduced |
| Alliancebernstein L.P. | 1,689,629 | $80.2M | 0.03% | +153,429+10.0% | Added |
| Geode Capital Management, LLC | 1,785,586 | $84.8M | 0.01% | +63,181+3.7% | Added |
| Alkeon Capital Management LLC | 1,850,934 | $87.9M | 0.40% | 00.0% | Unchanged |
| Bellevue Group AG | 2,389,314 | $113.4M | 2.36% | +404,042+20.4% | Added |
| State Street Corp | 3,414,306 | $162.1M | 0.01% | +668,742+24.4% | Added |
| Price T Rowe Associates Inc | 3,809,859 | $180.9M | 0.02% | −699,466−15.5% | Reduced |
| Avoro Capital Advisors LLC | 3,955,555 | $187.8M | 2.43% | +455,555+13.0% | Added |
| Deep Track Capital, LP | 4,000,978 | $190.0M | 5.30% | +958,380+31.5% | Added |
| Wellington Management Group LLP | 4,251,861 | $201.9M | 0.04% | +841,915+24.7% | Added |
| Vanguard Group Inc | 4,526,920 | $214.9M | 0.00% | −2,708−0.1% | Reduced |
| RTW Investments, LP | 5,477,561 | $260.1M | 3.20% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,702,634 | $270.8M | 0.00% | −76,778−1.3% | Reduced |
| General Atlantic LLC | 5,733,989 | $272.2M | 8.17% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 6,280,305 | $298.2M | 0.14% | −458,251−6.8% | Reduced |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −318,647−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −295,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −96,371−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −73,553−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −70,987−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −65,628−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −41,328−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −26,022−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −23,426−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −21,919−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −19,772−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −14,793−100.0% | Sold out |
| Symmetry Investments LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Hunting Hill Global Capital, LLC | 0 | $0 | 0.00% | −10,301−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −7,676−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −7,474−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −7,107−100.0% | Sold out |
| Palumbo Wealth Management LLC | 0 | $0 | 0.00% | −4,910−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −4,791−100.0% | Sold out |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −4,246−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −4,112−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −3,920−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −3,810−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −3,323−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,357−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Mid-American Wealth Advisory Group, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |